Treatment modalities of psoriatics over a 6-year period (1975-1981).
For an evaluation of the various treatments given to psoriatics, a total of 243 outpatients, all seen in 1975, were followed during a 6-year period. 18.1% underwent only one sort of treatment, 44.9% two sorts and 18.1% three sorts. The rest underwent four or more treatment modalities. Topical steroids were the most commonly used form of therapy given to 88.5%. Grenz-rays were given in small amounts to 73.3%, most often as a supplement to topical steroids. Methotrexate was given to 12.3%, PUVA to 13.6%, etretinate to 3.3% and UVB to 1.2%. 26.3% were treated as inpatients during the observation period, and finally 7.0% were treated at the Dead Sea.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005050:Etretinate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D005050:Etretinate; D008727:Methotrexate